BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 18007158)

  • 21. Enhancement and safety of iomeprol-400 and iodixanol-320 in patients undergoing abdominal multidetector CT.
    Romano L; Grazioli L; Bonomo L; Xu JR; Chen KM; Dore R; Vanzulli A; Catalano C
    Br J Radiol; 2009 Mar; 82(975):204-11. PubMed ID: 19064592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol.
    Barrett BJ; Katzberg RW; Thomsen HS; Chen N; Sahani D; Soulez G; Heiken JP; Lepanto L; Ni ZH; Ni ZH; Nelson R
    Invest Radiol; 2006 Nov; 41(11):815-21. PubMed ID: 17035872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the effect of low- and iso-osmolar contrast agents on heart rate during chest CT angiography: results of a prospective randomized multicenter study.
    Chartrand-Lefebvre C; White CS; Bhalla S; Mayo-Smith WW; Prenovault J; Vydareny KH; Soto JA; Ozkan OS; Chughtai AR; Soulez G
    Radiology; 2011 Mar; 258(3):930-7. PubMed ID: 21212367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography.
    Thomsen HS; Morcos SK; Erley CM; Grazioli L; Bonomo L; Ni Z; Romano L;
    Invest Radiol; 2008 Mar; 43(3):170-8. PubMed ID: 18301313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of a low-osmolar contrast medium, iopamidol, and an iso-osmolar contrast medium, iodixanol, in MDCT coronary angiography.
    Ozbulbul NI; Yurdakul M; Tola M
    Coron Artery Dis; 2010 Nov; 21(7):414-9. PubMed ID: 20671550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the efficacy and safety of iopamidol-370 and iodixanol-320 in patients undergoing multidetector-row computed tomography.
    Sahani DV; Soulez G; Chen KM; Lepanto L; Xu JR; Nelson RC; Grazioli L; Vanzulli A; Heiken JP;
    Invest Radiol; 2007 Dec; 42(12):856-61. PubMed ID: 18007158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiphasic contrast-enhanced multidetector-row CT of liver: contrast-enhancement theory and practical scan protocol with a combination of fixed injection duration and patients' body-weight-tailored dose of contrast material.
    Ichikawa T; Erturk SM; Araki T
    Eur J Radiol; 2006 May; 58(2):165-76. PubMed ID: 16417983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current contrast media delivery strategies for cardiac and pulmonary multidetector-row computed tomography angiography.
    Ramos-Duran LR; Kalafut JF; Hanley M; Schoepf UJ
    J Thorac Imaging; 2010 Nov; 25(4):270-7. PubMed ID: 21042065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast optimization and scan timing for single and multidetector-row computed tomography.
    Brink JA
    J Comput Assist Tomogr; 2003; 27 Suppl 1():S3-8. PubMed ID: 12908706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidetector row CT of the liver.
    Oto A; Tamm EP; Szklaruk J
    Radiol Clin North Am; 2005 Sep; 43(5):827-48, vii. PubMed ID: 16098342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast-induced nephropathy-choice of contrast agents to reduce renal risk.
    Katholi RE
    Am Heart Hosp J; 2009; 7(1):45-9. PubMed ID: 19742433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to design injection protocols for multiple detector-row CT angiography (MDCTA).
    Fleischmann D
    Eur Radiol; 2005 Dec; 15 Suppl 5():E60-5. PubMed ID: 18637231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety profile of new non-ionic contrast media: renal tolerance.
    Stacul F; Thomsen HS
    Eur J Radiol; 1996 Nov; 23 Suppl 1():S6-9. PubMed ID: 9056157
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.